Table: begin end state 1 6 cytoplasmic 7 26 transmembrane 27 31 non-cytoplasmic 32 52 transmembrane 53 91 cytoplasmic 92 111 transmembrane 112 116 non-cytoplasmic 117 138 transmembrane 139 158 cytoplasmic 159 183 transmembrane 184 190 non-cytoplasmic 191 211 transmembrane 212 220 cytoplasmic 221 240 transmembrane 241 255 non-cytoplasmic 256 276 transmembrane 277 284 cytoplasmic 285 305 transmembrane 306 324 non-cytoplasmic 325 345 transmembrane 346 369 cytoplasmic 370 392 transmembrane 393 398 non-cytoplasmic 399 421 transmembrane 422 440 cytoplasmic 441 458 transmembrane 459 469 non-cytoplasmic 470 490 transmembrane 491 514 cytoplasmic 515 534 transmembrane 535 547 non-cytoplasmic 548 571 transmembrane 572 577 cytoplasmic 578 598 transmembrane 599 647 non-cytoplasmic 648 670 transmembrane 671 701 cytoplasmic
Input: >14734 FitnessBrowser__Keio:14734 MNKSGKYLVWTVLSVMGAFALGYIALNRGEQINALWIVVASVCIYLIAYRFYGLYIAKNV LAVDPTRMTPAVRHNDGLDYVPTDKKVLFGHHFAAIAGAGPLVGPVLAAQMGYLPGMIWL LAGVVLAGAVQDFMVLFVSTRRDGRSLGELVKEEMGPTAGVIALVACFMIMVIILAVLAM IVVKALTHSPWGTYTVAFTIPLALFMGIYLRYLRPGRIGEVSVIGLVFLIFAIISGGWVA ESPTWAPYFDFTGVQLTWMLVGYGFVAAVLPVWLLLAPRDYLSTFLKIGTIVGLAVGILI MRPTLTMPALTKFVDGTGPVWTGNLFPFLFITIACGAVSGFHALISSGTTPKMLANEGQA CFIGYGGMLMESFVAIMALVSACIIDPGVYFAMNSPMAVLAPAGTADVVASAAQVVSSWG FSITPDTLNQIASEVGEQSIISRAGGAPTLAVGMAYILHGALGGMMDVAFWYHFAILFEA LFILTAVDAGTRAARFMLQDLLGVVSPGLKRTDSLPANLLATALCVLAWGYFLHQGVVDP LGGINTLWPLFGIANQMLAGMALMLCAVVLFKMKRQRYAWVALVPTAWLLICTLTAGWQK AFSPDAKVGFLAIANKFQAMIDSGNIPSQYTESQLAQLVFNNRLDAGLTIFFMVVVVVLA LFSIKTALAALKDPKPTAKETPYEPMPENVEEIVAQAKGAH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server